Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients

Author of publication Florin V. Chirila, Guang Xu, Dan Fontaine, Grant Kern, Tapan K. Khan, Jason Brandt, Yoshihiro Konishi, Gerhard Nebe‑von‑Caron, Charles L. White III & Daniel L. Alkon

Date of publication 30/11/2022

Synaps Dx

Clinical Study of Novel Skin Biomarker Test for Alzheimer’s Disease Gains Vigorous Physician Support in Long-Sought Early Detection Breakthrough Prev post

Part I: Accurately Diagnosing Alzheimer’s Disease: Shortcomings of Blood Biomarkers and Need for Definitive, Non-invasive Diagnostic Testing Next post

Part I: Accurately Diagnosing Alzheimer’s Disease: Shortcomings of Blood Biomarkers and Need for Definitive, Non-invasive Diagnostic Testing